Yüklüyor......

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial

BACKGROUND: Recently, we reported that the level of lathosterol, a cholesterol synthesis marker, was suppressed after 1 month of treatment with anagliptin, a dipeptidyl peptidase-4 inhibitor. In this study, we administered either anagliptin or miglitol, an alpha-glucosidase inhibitor, for 3 months i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med Res
Asıl Yazarlar: Iijima, Takahiro, Aoki, Kazutaka, Kondo, Yoshinobu, Terauchi, Yasuo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elmer Press 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011936/
https://ncbi.nlm.nih.gov/pubmed/32095176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4084
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!